Market Newsdesk

July 1, 2026 4:04 am

Alvotech further strengthens liquidity by securing term loan facility of $75 million

— $75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset Management

— Follows recent $165m equity raise strengthening cash position

— Including equity financing and undrawn loan facility, Alvotech has secured access to $240 million in new capital

— Funds will support execution across Alvotech’s R&D pipeline and global product launches

REYKJAVIK, Iceland, July 01, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has amended its existing credit agreement with funds managed by GoldenTree Asset Management LP and other existing lenders of Alvotech to provide a term loan facility of up to $75 million in additional capital.

The financing further strengthens Alvotech’s financial position following the $165 million equity capital raise announced on June 18, 2026, and supports the continued execution of the company’s growth strategy, including advancing its biosimilar pipeline, supporting product launches and expanding global commercial operations. Including the equity financing and the undrawn term loan facility the company has secured access to $240 million in new capital.

“This financing provides additional flexibility as we continue to execute on our strategic priorities and support the next phase of growth for Alvotech,” said Robert Wessman, founder and chairman of Alvotech. “The strong support we received from both existing shareholders and more than 40 new specialist healthcare investors in our recent equity offering, together with this additional financing, reflects growing confidence in Alvotech, our strategy and the opportunities ahead.

“Over the past several months we have achieved important milestones across our business, including the resubmission of key Biologics License Applications to the FDA, continued advancement of our pipeline including FDA acceptance of our BLA for a biosimilar to Entyvio^®, and the expansion of our global commercial footprint. These achievements reinforce our belief that we are building one of the world’s leading biosimilars companies.

“With approximately 30 biosimilar products in development and a growing portfolio of commercial opportunities, we see a significant opportunity to increase patient access to affordable biologic medicines around the world.

“Capital is the fuel that enables us to execute on that vision, and this financing further strengthens our ability to invest in growth and create long-term value for patients, partners and shareholders.”

The financing builds on Alvotech’s existing relationship with GoldenTree, which has been a long-term financing partner to the company. It expands the company’s existing credit agreement by providing an additional $75 million term loan facility alongside the $100 million term loan facility announced in December 2025. It bears an interest rate of 12.50%, payable monthly in cash, and has a maturity date of December 31, 2027.

For further information, contact:

Media

Benedikt Stefansson
Sarah MacLeod
[email protected]

Investors

Dr. Balaji V Prasad
Benedikt Stefansson
[email protected]

About Alvotech

Alvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in biosimilars by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Five biosimilars are already approved and marketed in multiple global markets, including biosimilars to Humira^® (adalimumab), Stelara^® (ustekinumab), Simponi^® (golimumab), Eylea^® (aflibercept) and Prolia^®/Xgeva^® (denosumab). The current development pipeline includes nine disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. For more information, please visit https://www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.

For more information, please visit our investor portal, and our website or follow us on social media on LinkedIn, Facebook, Instagram and YouTube.

Alvotech Forward Looking Statements

Certain statements in this communication may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include, for example, Alvotech’s expectations regarding the adequacy and comprehensiveness of the data package to support the demonstration of biosimilarity and interchangeability for AVT16, business prospects and opportunities including pipeline product development, including AVT16 and AVT80, future plans and intentions, regulatory review and interactions, the potential approval, interchangeable designation and commercial launch of its product candidates, and Alvotech’s mission to expand patient access to biologic medicines. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Alvotech and its management, are inherently uncertain and are inherently subject to risks, variability, and contingencies, many of which are beyond Alvotech’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in documents that Alvotech may from time-to-time file or furnish with the SEC. There may be additional risks that Alvotech does not presently know or that Alvotech currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, assurance, prediction or definitive statement of a fact or probability. Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred to in this communication. Alvotech disclaims any and all liability for any loss or damage (whether foreseeable or not) suffered or incurred by any person or entity as a result of anything contained or omitted from this communication and such liability is expressly disclaimed.

July 1, 2026 4:03 am

Willis launches CyMax Facility, a primary and excess facility aimed at SMEs and middle market companies in the EMEA region

LONDON, July 01, 2026 (GLOBE NEWSWIRE) — Willis, a WTW business (NASDAQ:WTW), today announced the expansion of its CyMax Facility, a primary and excess cyber facility designed specifically for SMEs and middle market companies across EMEA, in partnership with Insurers AXA XL, Beazley, HDI Global and Markel.

Building on the success of its previous Continental Europe facility, the renewed offering provides broader access, higher limits and faster execution for eligible companies seeking comprehensive cyber protection. It is designed to streamline the insurance experience for clients and brokers, while supporting companies facing exposures ranging from data breaches and ransomware to supply chain risks.

The cover supports clients through crisis management and incident response, with access to external expertise when a cyber event occurs. It also provides financial protection for business interruption and supply chain losses, alongside cover for evolving threats such as social engineering, telephone hacking and invoice manipulation, helping protect profitability, continuity and reputation.

Key features:

Panel-based capacity: The CyMax Facility has been expanded from a single-insurer model to a panel-based facility, supporting broader insurer participation and more flexible placement options for SMEs and middle market companies.
Simplified application process: A one-page Cyber Application Form and short eligibility questionnaire of six to eight underwriting questions helps streamline access to cover and reduce administrative burden for clients and brokers.
Broader and more inclusive eligibility: The facility is designed for companies with turnover up to €/CHF500m, who have established security controls, while also providing access to coverage for businesses with partially implemented controls in place.
Pre-agreed pricing grids: Pre-agreed pricing grids reduce the need for back-and-forth discussions with insurers, helping clients and brokers secure terms more efficiently.
Willis Cyber proprietary wordings: Clients benefit from WTW’s EMEA CyCore Primary and Excess wordings, aligned with GDPR, NIS2 and DORA, with innovative coverages such as cyber incident response, notification costs to data subjects and regulators, emergency costs, business interruption and contingent business interruption, regulatory action, social engineering, cyber theft, invoice manipulation and reputation harm.
Specialist cyber support: Clients can access EMEA expertise and insurer pre- and post-breach services, including pre-ransomware alerts, threat intelligence reports, onboarding calls and crisis exercises.

Brian Vosloh, Head of Cyber EMEA at Willis, said: “As cyber risks continue to grow in complexity, SMEs and middle market companies need cyber insurance solutions that are easier to access, quicker to place and better aligned to their evolving exposures.”

“By renewing and expanding Willis’ CyMax Facility, we are giving clients broader access to capacity, higher limits, innovative proprietary coverages and a faster, simpler route to cyber insurance. The use of pre-agreed pricing grids, a streamlined application process and a single vulnerability-scan subjectivity helps reduce friction for brokers and clients, while access to pre- and post-breach services offered by insurers supports stronger cyber resilience.”

About WTW

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in the areas of people, risk and capital. Leveraging the global view and local expertise of our colleagues serving 140 countries and markets, we help organizations sharpen their strategy, enhance organizational resilience, motivate their workforce and maximize performance.

Working shoulder to shoulder with our clients, we uncover opportunities for sustainable success—and provide perspective that moves you. Learn more at wtwco.com.

Media Contact

Jo Barrett
[email protected]
+44 (0)7940 703911

July 1, 2026 3:08 am

NiCE Extends Its AI-Powered Customer Experience Solution to AWS European Sovereign Cloud, Advancing Trusted Agentic AI Across Regulated Markets

NiCE Extends Its AI-Powered Customer Experience Solution to AWS European Sovereign Cloud, Advancing Trusted Agentic AI Across Regulated Markets

NiCE’s CX AI solution supports digital sovereignty and EU data residency requirements

HOBOKEN, N.J.–(BUSINESS WIRE)–NiCE (Nasdaq: NICE) today announced it has been named a launch partner for the Amazon Web Services, Inc. (AWS) European Sovereign Cloud, a new independent cloud for Europe. The announcement marks a further expansion of the strategic relationship between NiCE and AWS, with NiCE making its agentic AI-powered customer experience solution available on the AWS European Sovereign Cloud.

Through this collaboration, organizations will be able to deploy NiCE’s advanced AI capabilities while supporting their data residency, operational autonomy, and digital sovereignty requirements within the European Union (EU). Building on the companies’ previously announced partnership to accelerate AI-powered customer service innovation, this newest alliance extends the reach of NiCE’s agentic AI solution to its growing European customer base, particularly organizations operating in highly regulated industries such as public sector, financial services, and healthcare.

The AWS European Sovereign Cloud is a fully featured, independently operated sovereign cloud backed by strong technical controls, sovereign assurances, and legal protections designed to meet the needs of European governments and enterprises. The AWS European Sovereign Cloud infrastructure is entirely located within the EU and operates independently from existing AWS Regions. Customers using the AWS European Sovereign Cloud benefit from the full power of AWS, including the same service portfolio, security, availability, performance, familiar architecture, APIs, and innovations such as the AWS Nitro System. By making NiCE’s agentic AI solution available on the AWS European Sovereign Cloud, organizations in highly regulated industries can accelerate AI adoption and unlock greater business value while maintaining control over sensitive data and meeting digital sovereignty requirements.

Advancing Agentic AI for Regulated Markets

NiCE is a leader in CX AI, unifying AI agents and human agents to orchestrate intelligent, goal-oriented outcomes across the customer journey. With its agentic AI solution planned for availability on AWS European Sovereign Cloud, European organizations will be able to deploy AI agents, real-time copilots, workflow automation, and AI-powered analytics capabilities in an environment designed to meet digital sovereignty needs and support customer requirements.

For example, a European financial institution could deploy NiCE’s AI agents on AWS European Sovereign Cloud to automate routine service requests, support human agents with real-time guidance, and personalize customer interactions while maintaining operational autonomy and keeping customer data within the EU.

“What sets NiCE apart is enterprise-grade agentic AI engineered for the world’s most regulated organizations, purpose-built with reliability, security, compliance, and privacy that organizations can’t compromise on,” said Dorothy Copeland, Chief Partner Officer at NiCE. “By extending our agentic AI solution to the AWS European Sovereign Cloud, NiCE enables Europe’s most regulated organizations to deploy next-generation AI capabilities on an independent cloud infrastructure located within the EU, supporting their digital sovereignty needs while accelerating AI-first customer experience transformation.”

Supporting Europe’s Digital Sovereignty Priorities

Data governance and compliance remain top priorities for organizations operating under EU regulatory frameworks. NiCE’s sovereign cloud strategy, including existing deployments in the EU, U.K., and Australia, reflects its continued commitment to delivering secure, scalable, AI-driven CX solutions that support customers’ regional and regulatory requirements. The addition of the AWS European Sovereign Cloud gives customers an uncompromising choice: achieving total digital sovereignty while continuing to innovate at pace.

“As AI governance becomes a strategic priority across Europe, sovereign cloud environments are evolving from a compliance requirement to a key enabler of innovation. Organizations increasingly need solutions that not only meet stringent data residency and regulatory obligations, but also deliver the agentic AI, automation, and real-time insights required to transform customer experience,” said Oru Mohiuddin, Research Director, IDC. “The combination of NiCE’s agentic AI capabilities with the AWS European Sovereign Cloud addresses a growing market need: enabling regulated organizations to pursue AI-led transformation while maintaining control over data, operations, and governance within the EU.”

Thomas Pöppe, CIO, AOK Bayern: “As we operate in an increasingly complex regulatory and competitive environment, especially around the use of AI, we see sovereignty as becoming essential to our long-term AI strategy. The combination of NiCE’s agentic AI capabilities and the AWS European Sovereign Cloud offers a compelling path forward, allowing us to innovate while meeting evolving requirements around data residency, governance, and operational control.”

About NiCE

NiCE (NASDAQ: NICE) is transforming the world with AI that puts people first. Our purpose-built AI-powered platforms automate engagements into proactive, safe, intelligent actions, empowering individuals and organizations to innovate and act, from interaction to resolution. Trusted by organizations throughout 150+ countries worldwide, NiCE’s platforms are widely adopted across industries connecting people, systems, and workflows to work smarter at scale, elevating performance across the organization, delivering proven measurable outcomes.

Trademark Note: NiCE and the NiCE logo are trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE’s marks, please see: www.nice.com/nice-trademarks.

Forward-Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Ms. Copeland, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the “Company”). In some cases, such forward-looking statements can be identified by terms such as “believe,” “expect,” “seek,” “may,” “will,” “intend,” “should,” “project,” “anticipate,” “plan,” “estimate,” or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in general economic and business conditions; competition; successful execution of the Company’s growth strategy; success and growth of the Company’s cloud Software-as-a-Service business; rapid changes in technology and market requirements; the implementation of AI capabilities in certain products and services, decline in demand for the Company’s products; inability to timely develop and introduce new technologies, products and applications; difficulties in making additional acquisitions or difficulties or effectively integrating acquired operations; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Company’s dependency on third-party cloud computing platform providers, hosting facilities and service partners; cyber security attacks or other security incidents; privacy concerns; changes in currency exchange rates and interest rates, the effects of additional tax liabilities resulting from our global operations, the effect of unexpected events or geo-political conditions, including those arising from political instability or armed conflict that may disrupt our business and the global economy; our ability to recruit and retain qualified personnel; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the “SEC”). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company’s reports filed from time to time with the SEC, including the Company’s Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260701260975/en/

Corporate Media Contact

Christopher Irwin-Dudek, +1 201 561 4442, [email protected], ET

Investors

Ryan Gilligan, +1 551-417-2531, [email protected], ET

Omri Arens, +972 3 763-0127, [email protected], CET

KEYWORDS: Europe United States North America New Jersey

INDUSTRY KEYWORDS: Internet Data Management Technology Artificial Intelligence Software

MEDIA:

Logo

July 1, 2026 3:03 am

NiCE Launches AI Specialization Program, Recognizing Partners Driving Significant AI Outcomes for Enterprises

NiCE Launches AI Specialization Program, Recognizing Partners Driving Significant AI Outcomes for Enterprises

Six industry-leading partners — Accenture, Cirrus, Deloitte, Route 101, and TTEC — named as inaugural AI Specialization partners under the NiCE 360 Partner Program

HOBOKEN, N.J.–(BUSINESS WIRE)–NiCE (Nasdaq: NICE) today announced the launch of the NiCE AI Specialization Program, a formal, criteria-based recognition within the NiCE 360 Partner Program designed to recognize partners delivering measurable outcomes for enterprise organizations. As part of the launch, NiCE has named six inaugural AI Specialization partners: Accenture, Cirrus, Deloitte, TTEC, and Route 101.

The NiCE AI Specialization Program establishes one of the industry’s most rigorous standards for AI delivery. Modeled on industry-recognized frameworks, it gives enterprise buyers a trusted, independently verified way to identify the partners proven to deliver AI at scale, setting a new benchmark for enterprise AI delivery.

“Enterprises are placing significant investment in AI, and they need partners with deep AI skills and experience that provide advisory consulting and implementation services. The NiCE AI Specialization Partner Program sets that standard. It recognizes the partners who have proven they can turn NiCE AI into measurable business outcomes, and gives every enterprise a trusted, independently verified way to choose who to build with,” said Dorothy Copeland, Chief Partner Officer, NiCE.

Every AI Specialization partner is validated against three pillars — People, Practice and Performance — that together prove they can deliver enterprise AI at scale:

People: A bench of certified AI talent, including NiCE Certified AI Engineers (NCAE) at Practitioner level or above, Conversation Designers and dedicated AI Delivery Leads, so that every engagement is backed by credentialed human expertise.
Practice: Proven, live deployments across the NiCE AI suite, including Cognigy, Autopilot, Copilot, Auto Summary and Proactive AI, spanning at least three distinct use-case categories and one or more enterprise-scale engagements.
Performance: Independently verified business outcomes, including AI-attributed annual contract value (ACV), customer satisfaction (CSAT) scores, net retention and enterprise references that demonstrate measurable impact.

“The NiCE AI Specialization affirms our commitment to outcomes over promises. Being part of this first cohort reflects the depth of our certified talent and the impact of the deployments we deliver across the full NiCE AI suite,” said Jason Roos, CEO, Cirrus.

“The NiCE AI Specialization recognizes what our clients already experience: a partner that pairs deep NiCE expertise with a relentless focus on outcomes and quality. Being named in this first cohort validates the dedicated certified talent and proven deployments we bring to every engagement,” said Stephan Schuessler, Partner Technology & Transformation, Deloitte Consulting.

“Being named among the first AI Specialization partners reflects the standard we hold ourselves to on every engagement. This recognition is built on certified talent, live deployments, and the measurable outcomes our enterprise clients count on,” said Russell Attwood, CEO, Route 101.

“The enterprise market is flooded with AI hype, but technology alone doesn’t solve business challenges. True transformation requires connecting advanced tools with a company’s broader operational and technology ecosystem. Being recognized as both an inaugural NiCE AI Specialization partner and a Platinum Partner reinforces TTEC Digital’s ability to deliver the deep consulting and end-to-end integration required to make AI work at scale and drive meaningful outcomes,” said Chris Brown, President, TTEC Digital.

The AI Specialization Program is the first in a planned roadmap of Specializations under the NiCE 360 Partner Program. NiCE plans to roll out a series of product and vertical-market specializations throughout 2026 and 2027. As the program expands, enterprises will be able to choose partners with deep, validated expertise in their specific industry, pairing proven delivery with the domain knowledge that turns technology into measurable results in their market.

About the NiCE Certified AI Engineer (NCAE) Program

The NCAE program is an individual certification pathway that validates hands-on expertise in designing, deploying, and optimizing enterprise-grade AI agent solutions on the NiCE platform. Credentials are earned by individuals, not partner organizations, through a combination of self-paced learning, instructor-led workshops, and real-world deployment assessments. Levels include Associate, Practitioner, and Expert.

About NiCE

NiCE (Nasdaq: NICE) is transforming the world with AI that puts people first. Our purpose-built AI-powered platforms automate engagements into proactive, safe, intelligent actions, empowering individuals and organizations to innovate and act, from interaction to resolution. Trusted by organizations throughout 150+ countries worldwide, NiCE’s platforms are widely adopted across industries connecting people, systems, and workflows to work smarter at scale, elevating performance across the organization, delivering proven measurable outcomes.

Forward-Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Ms. Copeland, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the “Company”). In some cases, such forward-looking statements can be identified by terms such as “believe,” “expect,” “seek,” “may,” “will,” “intend,” “should,” “project,” “anticipate,” “plan,” “estimate,” or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in general economic and business conditions; competition; successful execution of the Company’s growth strategy; success and growth of the Company’s cloud Software-as-a-Service business; rapid changes in technology and market requirements; the implementation of AI capabilities in certain products and services, decline in demand for the Company’s products; inability to timely develop and introduce new technologies, products and applications; difficulties in making additional acquisitions ordifficulties or effectively integrating acquired operations; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Company’s dependency on third-party cloud computing platform providers, hosting facilities and service partners; cybersecurity attacks or other security incidents; privacy concerns; changes in currency exchange rates and interest rates, the effects of additional tax liabilities resulting from our global operations, the effect of unexpected events or geopolitical conditions, including those arising from political instability or armed conflict that may disrupt our business and the global economy; our ability to recruit and retain qualified personnel; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the “SEC”). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company’s reports filed from time to time with the SEC, including the Company’s Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260701795827/en/

Corporate Media Contact

Christopher Irwin-Dudek, +1 201-561-4442, [email protected], ET

Investors

Ryan Gilligan, +1 551-417-2531, [email protected], ET

Omri Arens, +972 3 763-0127, [email protected], CET

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Data Management Technology Software Networks Artificial Intelligence Internet

MEDIA:

Logo

July 1, 2026 3:03 am

Teledyne e2v Strengthens Space-Grade ADC Offering with Radiation Robustness Results

Teledyne e2v Strengthens Space-Grade ADC Offering with Radiation Robustness Results

GRENOBLE, France–(BUSINESS WIRE)–
Teledyne e2v Semiconductors today announced new radiation test results for its EV10AS940, a 10-bit, 12.8 GSps, Ka-band-capable analog-to-digital converter, or ADC, developed for demanding space payloads and mission-critical applications.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701621862/en/

EV10AS940 10-bit, 12.8 GSps space-grade analog-to-digital converter from Teledyne e2v Semiconductors.

These results give space engineers additional confidence when designing high-performance satellite communications payloads, synthetic aperture radar, or SAR, systems, space electronic intelligence platforms and advanced space instrumentation, where data-conversion speed, radiation tolerance and in-orbit reliability are critical to mission success.

As part of a comprehensive single event effects, or SEE, test campaign, multiple EV10AS940 samples were evaluated at leading radiation test facilities, including RADEF in Finland and the Texas A&M University Cyclotron Institute in the United States. The devices were exposed to heavy ions across a broad range of conditions, including linear energy transfer, or LET, values up to 94 MeV·cm²/mg.

Across all tested configurations, no single event latch-up, or SEL, events were observed, including at maximum LET levels, elevated temperature and increased supply-voltage conditions. At the conclusion of the campaign, all tested devices remained fully operational, with no functional degradation observed.

“These results give space system designers added confidence when selecting high-speed data converters for advanced payloads,” said Victoria Nasserddine, Product Marketing Manager at Teledyne e2v Semiconductors. “The EV10AS940 combines ultrahigh-speed performance with demonstrated radiation robustness, supporting applications where mission assurance and signal-chain performance are both critical.”

The EV10AS940 supports high-bandwidth applications that require fast, reliable conversion in harsh environments, including satellite communications, radar, electronic intelligence and advanced space instrumentation. The latest SEE results build on Teledyne e2v’s long-standing expertise in high-reliability semiconductor technologies for space and defense markets.

Total ionizing dose, or TID, characterization of the EV10AS940 has also been completed, confirming its robustness for long-term operation in radiation environments. Additional testing is ongoing, with complete reports expected by the end of 2026.

ABOUT TELEDYNE e2v SEMICONDUCTORS

Teledyne e2v delivers advanced solutions for health care, life sciences, space, transportation, defense and industrial markets. The company offers high-reliability semiconductors, including data converters, microprocessors and radiation-tolerant memories, alongside specialized manufacturing and test services. To learn more, visit Teledyne e2v Semiconductors’ website at semiconductors.teledyne-e2v.com.

ABOUT TELEDYNE

Teledyne Technologies Incorporated (NYSE:TDY) is a leading provider of sophisticated digital imaging products and software, instrumentation, aerospace and defense electronics, and engineered systems. Teledyne’s operations are primarily located in the United States, Canada, the United Kingdom, and Western and Northern Europe. For more information, visit Teledyne’s website at teledyne.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260701621862/en/

Jane Rohou – Marcom Manager

Email: [email protected]

KEYWORDS: France Europe

INDUSTRY KEYWORDS: Technology Other Defense Semiconductor Other Technology Aerospace Manufacturing Internet Hardware Data Management Defense

MEDIA:

Photo

EV10AS940 10-bit, 12.8 GSps space-grade analog-to-digital converter from Teledyne e2v Semiconductors.

Logo

July 1, 2026 2:42 am

CVLT Deadline: CVLT Investors with Losses in Excess of $100K Have Opportunity to Lead Commvault Systems, Inc. Securities Fraud Lawsuit

PR Newswire

NEW YORK, July 1, 2026 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Commvault Systems, Inc. (NASDAQ: CVLT) between April 29, 2025 and January 26, 2026, inclusive (the “Class Period”), of the important July 17, 2026 lead plaintiff deadline.

So what: If you purchased Commvault securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 17, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details Of The Case: According to the lawsuit, defendants provided overwhelmingly positive statements while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Commvault’s ARR growth environment; pertinently, Commvault knew or recklessly disregarded that its ARR growth guidance failed to properly factor in crucial variables, such as the type of sale. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cvlt-deadline-cvlt-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-commvault-systems-inc-securities-fraud-lawsuit-302815291.html

SOURCE THE ROSEN LAW FIRM, P. A.

July 1, 2026 2:40 am

CHX Deadline: CHX Investors with Losses in Excess of $100K Have Opportunity to Lead ChampionX Corporation Securities Fraud Lawsuit

PR Newswire

NEW YORK, July 1, 2026 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024 (the “Class Period”), of the important July 14, 2026 lead plaintiff deadline.

So what: If you sold ChampionX common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants throughout the Class Period failed to disclose material information, which artificially deflated the price of ChampionX common stock. On February 29, 2024, ChampionX received an unsolicited non-public offer from Schlumberger Limited to purchase all the outstanding shares of ChampionX for $36.70 per share. On March 7, 2024, Schlumberger raised its offer to $37.80 per share. The lawsuit alleges that while these offers were on the table and unknown to the investing public, ChampionX was repurchasing its common stock at market prices significantly below the prices offered by Schlumberger. ChampionX had an obligation to disclose that it had received a formal acquisition offer from Schlumberger or abstain from purchasing ChampionX stock from unsuspecting investors. During the Class Period, ChampionX’s average stock price was $33.32 per share. On Tuesday, April 2, 2024, during pre-market hours, ChampionX disclosed the merger with Schlumberger. The merger eventually closed on July 16, 2025, with Schlumberger acquiring ChampionX for $40.58 per share.

To join the ChampionX class action, go to https://rosenlegal.com/cases/championx-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

View original content to download multimedia:https://www.prnewswire.com/news-releases/chx-deadline-chx-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-championx-corporation-securities-fraud-lawsuit-302815288.html

SOURCE THE ROSEN LAW FIRM, P. A.

July 1, 2026 2:33 am

DNB Goes Live on the nCino Platform to Modernise and Scale Corporate Lending Across International Markets

nCino bringing intelligent lending to life at Norway’s largest financial institution

LONDON, July 01, 2026 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the platform for agentic AI banking, today announced that DNB has gone live on the nCino Platform, powering its corporate lending business, with plans to extend to SME lending next year.

Headquartered in Oslo, Norway, DNB serves over 2 million retail customers and more than 200,000 corporate clients across a global network of branches. As the world’s leading shipping- and seafood-bank and a major international player in the energy sector, DNB offers a comprehensive range of products and services.

To support its continuous growth ambitions and modernisation journey, DNB recognised the need to modernise core credit systems to create a strong foundation for long term business value.

“For 200 years, DNB has supported its customers through changes big and small,” said Cecilie Kirsebom Foyn-Bruun, Executive Vice President of Lending at DNB. “As we went through our own digital transformation, it made sense to go with a company who could support us through a big change.”

DNB selected the nCino Platform to support its ambitions, deploying nCino for Commercial Lending alongside Banking Advisor, nCino’s AI-powered conversational interface that embeds intelligence directly into banker workflows. Now live, following an nCino gold standard implementation supported by Deloitte, the Bank plans to continue the nCino rollout across branches in nine countries.

“With nCino, we get a future proof foundation to work more efficiently and smarter to create value for our Corporate customers across industries and markets,” added Foyn-Bruun. “The goal is that our bankers have what they need to do their best work: a single platform, connected data and the intelligence to move faster for our clients.”

“DNB is one of Europe’s most respected financial institutions, and we’re proud to be the platform they’ve chosen to power its next chapter,” added Joaquín de Valenzuela, Managing Director of EMEA at nCino. “This partnership speaks to the trust financial institutions across EMEA are placing in nCino, and we’re committed to growing alongside them. With the nCino Platform and its agentic capabilities, DNB will have the intelligence to make faster, data-informed decisions with AI that doesn’t just inform action but helps drive it.”

About nCino
nCino (NASDAQ: NCNO) is the platform for agentic AI banking. With over 2,700 customers worldwide — including community banks, credit unions, independent mortgage banks, and the largest financial entities globally — nCino offers a trusted, agentic platform purpose-built for financial services and regulated industries. By deploying AI agents alongside human teams, nCino’s dual workforce enables institutions to eliminate inefficiencies, sharpen decision-making and deliver better outcomes for the customers they serve. For more information, visit www.ncino.com.

About DNB

DNB is Norway’s largest financial services group and one of the largest in the Nordic region in terms of market capitalisation. The Group offers a full range of financial services, including loans, savings, advisory services, insurance and pension products for retail and corporate customers. For more information, visit www.dnb.no.

Media Contact
Riley Keyzer
[email protected]

Terje Andre Kvinlaug
[email protected]

Forward-Looking Statements: This press release contains forward-looking statements about nCino’s financial and operating results, which include statements regarding nCino’s future performance, outlook, guidance, the benefits from the use of nCino’s solutions, our strategies, and general business conditions. Forward-looking statements generally include actions, events, results, strategies and expectations and are often identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions and the negatives thereof. Any forward-looking statements contained in this press release are based upon nCino’s historical performance and its current plans, estimates, and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent nCino’s expectations as of the date of this press release. Subsequent events may cause these expectations to change and, except as may be required by law, nCino does not undertake any obligation to update or revise these forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially including, but not limited to risks associated with (i) adverse changes in the financial services industry, including as a result of customer consolidation or bank failures; (ii) adverse changes in economic, regulatory, or market conditions, including as a direct or indirect consequence of higher interest rates; (iii) risks associated with acquisitions we undertake, (iv) breaches in our security measures or unauthorized access to our customers’ or their clients’ data; (v) the accuracy of management’s assumptions and estimates; (vi) our ability to attract new customers and succeed in having current customers expand their use of our solution, including in connection with our migration to an asset-based pricing model; (vii) competitive factors, including pricing pressures and migration to asset-based pricing, consolidation among competitors, entry of new competitors, the launch of new products and marketing initiatives by our competitors, and difficulty securing rights to access or integrate with third party products or data used by our customers; (viii) the rate of adoption of our newer solutions and the results of our efforts to sustain or expand the use and adoption of our more established solutions; (ix) fluctuation of our results of operations, which may make period-to-period comparisons less meaningful; (x) our ability to manage our growth effectively including expanding outside of the United States; (xi) adverse changes in our relationship with Salesforce; (xii) our ability to successfully acquire new companies and/or integrate acquisitions into our existing organization; (xiii) the loss of one or more customers, particularly any of our larger customers, or a reduction in the number of users our customers purchase access and use rights for; (xiv) system unavailability, system performance problems, or loss of data due to disruptions or other problems with our computing infrastructure or the infrastructure we rely on that is operated by third parties; (xv) our ability to maintain our corporate culture and attract and retain highly skilled employees; and (xvi) the outcome and impact of legal proceedings and related fees and expenses.

July 1, 2026 2:05 am

Ecopetrol Group receives payment for 100% of the FEPC account receivable balance for the second quarter of 2025

PR Newswire

BOGOTÁ, Colombia, July 1, 2026 /PRNewswire/ — Ecopetrol S.A. (BVC: ECOPETROL) (NYSE: EC) (the “Company”) hereby announces that the National Government, through Resolution 1492 dated June 30, 2026, issued by the Ministry of Finance and Public Credit (“MHCP”), recognized and ordered payment to the Ecopetrol Group in an aggregate amount of approximately COP 1 trillion, corresponding to the account receivable from the Fuel Price Stabilization Fund (“FEPC”) for the second quarter of 2025.

Of this aggregate amount, approximately COP 0.8 trillion corresponds to the Company and approximately COP 0.2 trillion to Refinería de Cartagena S.A.S. The payment was made through the issuance and delivery of short-term Class B Treasury Securities (TES) (TCO), in accordance with the MHCP’s resolution.

The payment reflects coordination among the Company, the National Government, the MHCP and the Ministry of Mines and Energy to implement mechanisms designed to reduce recognized FEPC balances owed to the Ecopetrol Group.

Ecopetrol is the largest company in Colombia and one of the main integrated energy companies in the American continent, with more than 19,000 employees. In Colombia, it is responsible for more than 60% of the hydrocarbon production of most transportation, logistics, and hydrocarbon refining systems, and it holds leading positions in the petrochemicals and gas distribution segments. With the acquisition of 51.4% of ISA’s shares, the company participates in energy transmission, the management of real-time systems (XM), and the Barranquilla–Cartagena coastal highway concession. At the international level, Ecopetrol has a stake in strategic basins in the American continent, with drilling and exploration operations in the United States (Permian basin and the Gulf of Mexico), Brazil, and Mexico, and, through ISA and its subsidiaries, Ecopetrol holds leading positions in the power transmission business in Brazil, Chile, Peru, and Bolivia, road concessions in Chile, and the telecommunications sector.

This release contains statements that may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. All forward-looking statements, whether made in this release or in future filings or press releases, or orally, address matters that involve risks and uncertainties, including in respect of the Company’s prospects for growth and its ongoing access to capital to fund the Company’s business plan, among others. Consequently, changes in the following factors, among others, could cause actual results to differ materially from those included in the forward-looking statements: market prices of oil & gas, our exploration, and production activities, market conditions, applicable regulations, the exchange rate, the Company’s competitiveness and the performance of Colombia’s economy and industry, to mention a few. We do not intend and do not assume any obligation to update these forward-looking statements.

For more information, please contact:

Investor Relations Office

Email:

[email protected]

Head of Corporate Communications (Colombia)

Marcela Ulloa

Email:

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/ecopetrol-group-receives-payment-for-100-of-the-fepc-account-receivable-balance-for-the-second-quarter-of-2025-302815451.html

SOURCE Ecopetrol S.A.

July 1, 2026 2:03 am

Kimball Electronics Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.

Kimball Electronics Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.

Helvoet is an advanced medical CDMO specializing in highly automated micro-molding and precision injection molding for microfluidics, diagnostics, and drug delivery applications

Acquisition establishes a global medical CMO platform by expanding the Kimball manufacturing footprint in Europe while adding production facilities in India

Transaction is expected to be accretive to fiscal 2027 adjusted earnings, increasing sales in the Kimball medical vertical in the low double-digit range

Helvoet customer base includes blue-chip medical companies complementary to the Kimball portfolio, creating opportunities for expanded program wins and possible vertical integration

Kimball manufacturing facility in Indianapolis positions the combined business to capture near-term U.S. demand from existing Helvoet customers

Management to host a conference call and webcast on Wednesday, July 1^stat 9:00 AM ET

JASPER, Ind.–(BUSINESS WIRE)–
Kimball Electronics, Inc. (Nasdaq: KE) today announced the Company acquired Helvoet Polymer Technologies B.V. (“Helvoet”), a Contract Development and Manufacturing Organization (CDMO), based in Europe and with operations in India focused on microfluidics, diagnostics, and drug delivery.

The transaction was valued at a purchase price of €90 million (excluding working capital, other customary adjustments, and acquisition-related costs), or approximately $103 million, representing approximately 9x estimated adjusted EBITDA for Helvoet in calendar 2026. Kimball funded the acquisition through a combination of cash and available borrowing capacity on existing lines of credit. Pro forma leverage following the close remains consistent with the capital allocation priorities of Kimball.

Commenting on today’s announcement, Richard D. Phillips, Chief Executive Officer of Kimball Electronics, stated, “Helvoet is exactly the type of acquisition we’ve been building toward, a highly specialized medical CDMO with comprehensive capabilities in microfluidics, diagnostics, and drug delivery, serving blue-chip customers in the fastest-growing segments of healthcare. The acquisition is central to our strategy of establishing Kimball as a true global medical CMO platform with a strengthened presence in Europe, access to the India market, and a clear path for accelerating growth in the U.S. by leveraging our new manufacturing facility in Indianapolis.”

Mr. Phillips continued, “Today’s announcement is another meaningful step in our journey to expand our CMO capabilities and strategically position the Company with an increased presence and penetration in the medical industry. Over the past three years, we have made deliberate decisions that involved divesting non-core assets, streamlining our network, and strengthening the balance sheet. We are now leveraging that strength with the acquisition of a high-quality business at an attractive valuation. Helvoet has a talented team with strong leadership, and we’re excited to partner together and unlock synergies of the combined business. We believe this will create meaningful long-term value for our shareholders.”

Mr. Phillips and other members of the Kimball management team will be hosting a conference call and webcast on Wednesday, July 1, 2026, at 9:00 AM ET, to provide additional information on the acquisition and answer questions related to the transaction.

Based in the Netherlands, Helvoet was founded in 1939 and most recently operated as a wholly-owned subsidiary of Hydratec Industries N.V., with manufacturing facilities in Tilburg, Netherlands, and Pune, India. In calendar 2025, revenue totaled approximately $56 million with an EBITDA margin rate in the mid-teens. Over 70% of revenue was from medical customers and the balance derived from other end markets that deliver strong margins and support continued reinvestment in the medical business.

Eveline Hogenkamp, Chief Executive Officer of Helvoet, added: “Helvoet has spent decades building something genuinely differentiated — design and engineering savvy, robust materials expertise, highly automated precision manufacturing, and long-term relationships with some of the world’s leading medical companies. Finding the right partner to take this business to the next level was critical, and in Kimball we found just that. Their Indianapolis facility, customer relationships, and operational capabilities are precisely what we need to scale our U.S. presence and win larger, more complex programs. The strategic fit is as strong as any I’ve seen — complementary capabilities, shared values around engineering excellence and quality, and a clear vision for where this business can go. I couldn’t be more excited about what we’re going to build together.”

Helvoet will continue to be led by its current leadership team, including CEO Hogenkamp, who will remain a key driver of the business going forward.

MP Corporate Finance served as the lead financial advisor to Helvoet, and Roth Capital Partners served as the exclusive financial advisor to Kimball Electronics.

Additional information on the acquisition is available in the Kimball Electronics Form 8-K filed with the Securities and Exchange Commission (“SEC”).

	Conference Call / Webcast

	Date:	Wednesday, July 1, 2026

	Time:	9:00 AM Eastern Time

	Live Webcast:	investors.kimballelectronics.com/events-and-presentations/events

	Dial-in #:	877-407-8293 (or 201-689-8349)

	For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com.

About Kimball Electronics, Inc.

Kimball Electronics is a global, multifaceted manufacturer offering Electronics Manufacturing Services (EMS) and Contract Manufacturing Organization (CMO) solutions to customers around the world. From our operations in the United States, China, Mexico, Poland, Romania, and Thailand, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana.

To learn more about Kimball Electronics, visit www.kimballelectronics.com.

About Helvoet Polymer Technologies B.V.

Helvoet is a Contract Development and Manufacturing Organization (CDMO) for high-performance components in polymers and elastomers used in critical applications across health tech, food tech, new energy and mobility. They co-develop, manufacture and assemble precision components that meet the demands of regulated and high-performance environments. With approximately 85 years of experience, Helvoet combines deep materials expertise, in-house tooling and scalable production capacity to help customers move from concept to validated production with confidence.

Forward Looking Statements

Certain statements contained within this release are considered forward-looking, including our guidance, under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as “expect,” “should,” “goal,” “predict,” “will,” “future,” “optimistic,” “confident,” and “believe.” Undue reliance should not be placed on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. These forward-looking statements are subject to risks and uncertainties including, without limitation, global economic conditions, geopolitical environment and conflicts such as war, global health emergencies, availability or cost of raw materials and components, tariffs and other trade barriers, foreign exchange rate fluctuations, and our ability to convert new business opportunities into customers and revenue. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the company are contained in its Annual Report on Form 10-K for the year ended June 30, 2025.

Lasting relationships. Global success.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260630795051/en/

Andrew D. Regrut

Vice President, Investor Relations, Strategic Development, and Treasurer

812.827.4151

[email protected]

KEYWORDS: United States India North America Asia Pacific Europe Netherlands Indiana

INDUSTRY KEYWORDS: Technology Health Manufacturing Other Health Machinery Pharmaceutical Other Science Other Technology General Health Hardware Science Other Manufacturing Electronic Design Automation Consumer Electronics

MEDIA:

Logo